DMPClass I
Digoxin Control Serum, Ria
21 CFR 862.3280 / Clinical Toxicology
DMP is the FDA product code for Digoxin Control Serum, Ria, a class I device type, regulated under 21 CFR 862.3280. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DMP
- Device name
- Digoxin Control Serum, Ria
- Regulation
- 21 CFR 862.3280
- Device class
- Class I
- Review panel
- Clinical Toxicology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code DMP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1977 | 1 |
| 1978 | 1 |
| 1995 | 1 |
| 1997 | 1 |
Applicants with the most clearances
Product code DMP| Applicant | Clearances |
|---|---|
| Boehringer Mannheim Corp. | 1 |
| Chimera Research & Chemical, Inc. | 1 |
| Nuclear Medical Laboratories, Inc. | 1 |
| Pcl-Ria, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code DMP.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
